These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 8615700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T, Petrash JM.
    Biochemistry; 1996 Aug 27; 35(34):11196-202. PubMed ID: 8780524
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
    Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P.
    Mol Pharmacol; 1984 May 27; 25(3):425-30. PubMed ID: 6427599
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA, Gabbay KH, Grimshaw CE, Bohren KM.
    Biochemistry; 1995 Sep 05; 34(35):11264-75. PubMed ID: 7669785
    [Abstract] [Full Text] [Related]

  • 7. [Inhibitory effect of 7 agents on bovine testis aldose reductase].
    Liu C, Zhu X.
    Zhongguo Zhong Yao Za Zhi; 1997 Jun 05; 22(6):372-3, inside back cover. PubMed ID: 11038893
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Regulation of crystalline lens aldose reductase activity. Nonhyperbolic oxidation kinetics of NADPH by glucose].
    Vartanov SS, Pavlov AR, Iaropolov AI.
    Biokhimiia; 1990 Nov 05; 55(11):2046-57. PubMed ID: 2128191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding.
    Bhatnagar A, Liu SQ, Ueno N, Chakrabarti B, Srivastava SK.
    Biochim Biophys Acta; 1994 Apr 13; 1205(2):207-14. PubMed ID: 8155699
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?
    Colciago A, Negri-Cesi P, Celotti F.
    Exp Clin Endocrinol Diabetes; 2002 Jan 13; 110(1):22-6. PubMed ID: 11835121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modification of aldose reductase by S-nitrosoglutathione.
    Chandra A, Srivastava S, Petrash JM, Bhatnagar A, Srivastava SK.
    Biochemistry; 1997 Dec 16; 36(50):15801-9. PubMed ID: 9398310
    [Abstract] [Full Text] [Related]

  • 17. The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition.
    Bohren KM, Grimshaw CE.
    Biochemistry; 2000 Aug 15; 39(32):9967-74. PubMed ID: 10933817
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.